
HoHo Biotech, founded in 2017 by Benson Wang, specializes in hydrogen-based molecular medicine focusing on autoimmune diseases and gut microenvironment research. The company develops patented hydrogen capsules made from natural coral calcium, approved for prescription use in regional hospitals and medical centers in Taiwan. HoHo Biotech integrates AI molecular simulation and computational modeling to advance its Molecular Intelligence Engine, supporting precision hydrogen therapies. It has published over 18 medical papers validating its hydrogen capsules as effective adjuvants in autoimmune treatment. The company markets its products through pharmacy chains and serves medical centers, hospitals, clinics, and medical aesthetics, aiming to become a mainstream medical adjuvant provider worldwide.

HoHo Biotech, founded in 2017 by Benson Wang, specializes in hydrogen-based molecular medicine focusing on autoimmune diseases and gut microenvironment research. The company develops patented hydrogen capsules made from natural coral calcium, approved for prescription use in regional hospitals and medical centers in Taiwan. HoHo Biotech integrates AI molecular simulation and computational modeling to advance its Molecular Intelligence Engine, supporting precision hydrogen therapies. It has published over 18 medical papers validating its hydrogen capsules as effective adjuvants in autoimmune treatment. The company markets its products through pharmacy chains and serves medical centers, hospitals, clinics, and medical aesthetics, aiming to become a mainstream medical adjuvant provider worldwide.